Literature DB >> 18489212

The heterogeneous structure of schizotypal personality disorder: item-level factors of the Schizotypal Personality Questionnaire and their associations with obsessive-compulsive disorder symptoms, dissociative tendencies, and normal personality.

Michael Chmielewski1, David Watson.   

Abstract

A. Raine et al.'s (1994) 3-factor scheme is currently the most widely accepted model of schizotypal personality disorder (SPD). Factor analytic studies of the Schizotypal Personality Questionnaire (SPQ; A. Raine, 1991) subscales, which represent the 9 Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for SPD, have provided the model's primary support. The use of only 9 modeled variables, however, limits the number of factors that can be extracted. To explicate this structure more fully, the authors conducted item-level factor analyses of the SPQ in a large student sample that completed the instrument twice within a 2-week interval. The authors' analyses failed to support either the 3-factor model of SPD or the 9 existing DSM-based subscales of the SPQ. Instead, 5 replicable dimensions emerged that capture recurrent symptom pairings found in the broader SPD literature: Social Anhedonia, Unusual Beliefs and Experiences, Social Anxiety, Mistrust, and Eccentricity/Oddity. These factors are only weakly correlated with each other and show differential correlational patterns with the Big Five personality traits, dissociative tendencies, and symptoms of obsessive-compulsive disorder. Moreover, they are congruent with dimensional models of personality psychopathology. Implications for SPD in DSM-V are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18489212     DOI: 10.1037/0021-843X.117.2.364

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  17 in total

1.  Treatment of personality pathology through the lens of the hierarchical taxonomy of psychopathology: Developing a research agenda.

Authors:  Stephanie N Mullins-Sweatt; Christopher J Hopwood; Michael Chmielewski; Neil A Meyer; Jiwon Min; Ashley C Helle; Maggie D Walgren
Journal:  Personal Ment Health       Date:  2019-07-31

Review 2.  The assessment of schizotypy and its clinical relevance.

Authors:  Oliver J Mason
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

3.  Progress in achieving quantitative classification of psychopathology.

Authors:  Robert F Krueger; Roman Kotov; David Watson; Miriam K Forbes; Nicholas R Eaton; Camilo J Ruggero; Leonard J Simms; Thomas A Widiger; Thomas M Achenbach; Bo Bach; R Michael Bagby; Marina A Bornovalova; William T Carpenter; Michael Chmielewski; David C Cicero; Lee Anna Clark; Christopher Conway; Barbara DeClercq; Colin G DeYoung; Anna R Docherty; Laura E Drislane; Michael B First; Kelsie T Forbush; Michael Hallquist; John D Haltigan; Christopher J Hopwood; Masha Y Ivanova; Katherine G Jonas; Robert D Latzman; Kristian E Markon; Joshua D Miller; Leslie C Morey; Stephanie N Mullins-Sweatt; Johan Ormel; Praveetha Patalay; Christopher J Patrick; Aaron L Pincus; Darrel A Regier; Ulrich Reininghaus; Leslie A Rescorla; Douglas B Samuel; Martin Sellbom; Alexander J Shackman; Andrew Skodol; Tim Slade; Susan C South; Matthew Sunderland; Jennifer L Tackett; Noah C Venables; Irwin D Waldman; Monika A Waszczuk; Mark H Waugh; Aidan G C Wright; David H Zald; Johannes Zimmermann
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

4.  Ten-year rank-order stability of personality traits and disorders in a clinical sample.

Authors:  Christopher J Hopwood; Leslie C Morey; M Brent Donnellan; Douglas B Samuel; Carlos M Grilo; Thomas H McGlashan; M Tracie Shea; Mary C Zanarini; John G Gunderson; Andrew E Skodol
Journal:  J Pers       Date:  2013-02-05

5.  Schizophrenia in the internalizing-externalizing framework: a third dimension?

Authors:  Roman Kotov; Su-Wei Chang; Laura J Fochtmann; Ramin Mojtabai; Gabrielle A Carlson; Mark J Sedler; Evelyn J Bromet
Journal:  Schizophr Bull       Date:  2010-03-31       Impact factor: 9.306

6. 

Authors:  Robert F Krueger; Roman Kotov; David Watson; Miriam K Forbes; Nicholas R Eaton; Camilo J Ruggero; Leonard J Simms; Thomas A Widiger; Thomas M Achenbach; Bo Bach; R Michael Bagby; Marina A Bornovalova; William T Carpenter; Michael Chmielewski; David C Cicero; Lee Anna Clark; Christopher Conway; Barbara DeClercq; Colin G DeYoung; Anna R Docherty; Laura E Drislane; Michael B First; Kelsie T Forbush; Michael Hallquist; John D Haltigan; Christopher J Hopwood; Masha Y Ivanova; Katherine G Jonas; Robert D Latzman; Kristian E Markon; Joshua D Miller; Leslie C Morey; Stephanie N Mullins-Sweatt; Johan Ormel; Praveetha Patalay; Christopher J Patrick; Aaron L Pincus; Darrel A Regier; Ulrich Reininghaus; Leslie A Rescorla; Douglas B Samuel; Martin Sellbom; Alexander J Shackman; Andrew Skodol; Tim Slade; Susan C South; Matthew Sunderland; Jennifer L Tackett; Noah C Venables; Irwin D Waldman; Monika A Waszczuk; Mark H Waugh; Aidan G C Wright; David H Zald; Johannes Zimmermann
Journal:  Ann Med Psychol (Paris)       Date:  2021-01-08       Impact factor: 0.380

7.  Initial construction of a maladaptive personality trait model and inventory for DSM-5.

Authors:  R F Krueger; J Derringer; K E Markon; D Watson; A E Skodol
Journal:  Psychol Med       Date:  2011-12-08       Impact factor: 7.723

8.  The role of aberrant salience and self-concept clarity in psychotic-like experiences.

Authors:  David C Cicero; Theresa M Becker; Elizabeth A Martin; Anna R Docherty; John G Kerns
Journal:  Personal Disord       Date:  2012-03-05

Review 9.  On the specificity of positive emotional dysfunction in psychopathology: evidence from the mood and anxiety disorders and schizophrenia/schizotypy.

Authors:  David Watson; Kristin Naragon-Gainey
Journal:  Clin Psychol Rev       Date:  2009-11-12

10.  DSM-IV schizotypal personality disorder: a taxometric analysis among individuals with and without substance use disorders in the general population.

Authors:  Bradley T Kerridge; Tulshi D Saha; Deborah S Hasin
Journal:  Ment Health Subst Use       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.